The calcitonin (CT) concentration has been determined in the serum of 17 patients with different pituitary diseases. More or less elevated levels were found in 7 of them. No definite correlation has been observed between the immunoreactive CT and the different pituitary hormones.

Acromegaly↗

PubMedDate not supplied

[X-ray bone densitometry. Study of in vitro and in vivo reproducibility].

We studied the reproducibility in vitro and in vivo of a new bone densitometer (HOLOGIC QDR-1000, software version 4.03) which uses an x-ray source at two different levels of energy. Short and long term coefficient of variation (c.v.) in vitro is less than 0.5%. In vivo c.v. is less than 1% in normal body weight subjects and less than 3% in obese subjects. The ingestion of 500 mg of calcium element did not modify bone mineral density (BMD), while 1000 mg determined an increase of BMD equal to 2.6% and 1.5% in the two subjects examined. The increase of water thickness on a three femoral heads phantom caused a progressive reduction of bone mineral content (BMC) and BMD until 12.1% less than basal value and an increase of c.v. from 0.1% to 1%. The addition of oil to water at different percentages determined a slight increase of both BMC and BMD, till 3.5% with 66% of oil in water, if compared with the values obtained with water alone. The reduction of soft tissue around the bone determined a progressive decrease of BMD reaching 3.4% less than basal value when the reduction was 30%.

Absorptiometry, Photon↗

PubMedDate not supplied

[Treatment of male hypogonadotropic hypogonadism].

Males affected by hypogonadotropic hypogonadism can be treated with androgen replacement therapy, if they do not wish fertility. In order to limit or avoid androgen toxicity on the liver, it is possible to use testosterone undecanoate (which is absorbed in the gut by lymphatic system) at the dose of 160-240 mg/die or testosterone esters administered intramuscolarly at the dose of 250 mg/month. Estradiol and DHT derived from testosterone catabolism can be in excess therefore they can be provoke toxic phenomena, even if slight, such as gynecomastia or prostatic diseases. If patients wish fertility, they must be treated with gonadotropins or pulsatile LHRH. Therapeutic effects are very different depending on the different origin of the hypogonadism. In postpubertal onset hypogonadotropic hypogonadism, the response is constant and rapid; sperm count normalization can be reached within 6 months with the only hCG. Prepubertal onset hypogonadotropic hypogonadal men need hu-FSH too and longer treatment (18-24 months); sperm count normalization can be reached in less than half case. Nevertheless fertility can be reached even in oligozoospermic stage. Negative prognostic factors are: pan-hypopituitarism, cryptorchidism, how old are the patients at the beginning of the treatment and small testis volume. It is not yet clear if pulsatile LHRH therapy is profitable in terms of therapeutic results.

Gonadotropins↗